---
figid: PMC3924851__fig-2
figlink: /pmc/articles/PMC3924851/figure/f2/
number: F2
caption: 'Activation of JAK/STAT and PI3K/AKT/mTOR pathways by type I interferons
  (IFNs). Type I IFNs bind to type I IFN receptor, which comprises 2 subunits on the
  cell surface, interferon receptor subunit 1 (IFNAR1) and 2 (IFNAR2). Two kinases
  associate with the IFN receptor: Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2).
  The binding of type I IFN to its receptor leads to the activation of JAK1 and TYK2,
  which subsequently mediate phosphorylation of signal transducer and activator of
  transcription 1 (STAT1) and STAT2, which in turn is necessary for the formation
  of a complex with IRF9 (ISGF3). This complex translocates to the nucleus, where
  it binds to IFN-stimulated response elements (ISREs), resulting in the transcription
  of interferon-stimulated genes (ISGs). Additionally, IFN activates the PI3K/AKT/mTOR
  pathway. Activation of this pathway is dependent on JAK1/TYK2, which phosphorylate
  insulin receptor substrate 1 (IRS1) and 2 (IRS2). Phosphorylation of IRS1 and IRS2
  leads to the activation of PI3K, which subsequently activates mammalian target of
  rapamycin complex 1 (mTORC1). MTORC1 activates ribosomal protein S6 kinase (RPS6KB,
  also known as p70S6 kinase), which then phosphorylates ribosomal protein S6 (RPS6),
  leading to initiation of mRNA translation. Additionally, mTORC1 also regulates phosphorylation
  of eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1, also
  known as translation repressor 4EBP1). Phosphorylation of EIF4EBP1 causes inactivation
  of EIF4EBP1, which then dissociates from eukaryotic translation–initiation factor
  E (EIF4E), leading to initiation of cap-dependent mRNA translation. Type I IFN also
  activates rapamycin-insensitive complex (mTORC2), which is required for phosphorylation
  of RPS6KB, RPS6, and EIF4BP1. Although upstream signals leading to the activation
  of mTORC2 complex by type I IFN remain unclear, mTORC2 can activate AKT (Ser437),
  which plays a role in cell survival and has multiple targets, for example, forkhead
  box transcription factors (FOXO3). Interestingly, FOXO3 is considered a regulator
  of the transcription of some IFN-stimulated and autophagy genes. Inhibition of mTORC1
  leads to the induction of autophagy. Ubiquitin-like conjugation systems composed
  of a variety of autophagy-related proteins (Atg) are involved in the process of
  vesicle expansion and completion. Bafilomycin A1 blocks fusion between autophagosomes
  and lysosomes.'
pmcid: PMC3924851
papertitle: 'New Function of Type I IFN: Induction of Autophagy.'
reftext: Hana Schmeisser, et al. J Interferon Cytokine Res. 2014 Feb 1;34(2):71-78.
pmc_ranked_result_index: '231832'
pathway_score: 0.9576247
filename: fig-2.jpg
figtitle: 'New Function of Type I IFN: Induction of Autophagy'
year: '2014'
organisms:
- Homo sapiens
ndex: e760f758-dee5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3924851__fig-2.html
  '@type': Dataset
  description: 'Activation of JAK/STAT and PI3K/AKT/mTOR pathways by type I interferons
    (IFNs). Type I IFNs bind to type I IFN receptor, which comprises 2 subunits on
    the cell surface, interferon receptor subunit 1 (IFNAR1) and 2 (IFNAR2). Two kinases
    associate with the IFN receptor: Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2).
    The binding of type I IFN to its receptor leads to the activation of JAK1 and
    TYK2, which subsequently mediate phosphorylation of signal transducer and activator
    of transcription 1 (STAT1) and STAT2, which in turn is necessary for the formation
    of a complex with IRF9 (ISGF3). This complex translocates to the nucleus, where
    it binds to IFN-stimulated response elements (ISREs), resulting in the transcription
    of interferon-stimulated genes (ISGs). Additionally, IFN activates the PI3K/AKT/mTOR
    pathway. Activation of this pathway is dependent on JAK1/TYK2, which phosphorylate
    insulin receptor substrate 1 (IRS1) and 2 (IRS2). Phosphorylation of IRS1 and
    IRS2 leads to the activation of PI3K, which subsequently activates mammalian target
    of rapamycin complex 1 (mTORC1). MTORC1 activates ribosomal protein S6 kinase
    (RPS6KB, also known as p70S6 kinase), which then phosphorylates ribosomal protein
    S6 (RPS6), leading to initiation of mRNA translation. Additionally, mTORC1 also
    regulates phosphorylation of eukaryotic translation initiation factor 4E binding
    protein 1 (EIF4EBP1, also known as translation repressor 4EBP1). Phosphorylation
    of EIF4EBP1 causes inactivation of EIF4EBP1, which then dissociates from eukaryotic
    translation–initiation factor E (EIF4E), leading to initiation of cap-dependent
    mRNA translation. Type I IFN also activates rapamycin-insensitive complex (mTORC2),
    which is required for phosphorylation of RPS6KB, RPS6, and EIF4BP1. Although upstream
    signals leading to the activation of mTORC2 complex by type I IFN remain unclear,
    mTORC2 can activate AKT (Ser437), which plays a role in cell survival and has
    multiple targets, for example, forkhead box transcription factors (FOXO3). Interestingly,
    FOXO3 is considered a regulator of the transcription of some IFN-stimulated and
    autophagy genes. Inhibition of mTORC1 leads to the induction of autophagy. Ubiquitin-like
    conjugation systems composed of a variety of autophagy-related proteins (Atg)
    are involved in the process of vesicle expansion and completion. Bafilomycin A1
    blocks fusion between autophagosomes and lysosomes.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA1
  - AKT3
  - GAST
  - FOXO6
  - GNAT1
  - EIF4EBP1
  - FOXO3
  - IFNE
  - FOXO4
  - ATG12
  - AKT2
  - GNAZ
  - GNA11
  - AKT1
  - ATG10
  - EIF4E
  - GNAI2
  - EIF4B
  - FOXO1
  - IFNB1
  - IFNAR2
  - IFNK
  - STAT1
  - IRF9
  - IRS1
  - GNAT2
  - GNAI1
  - ATG7
  - JAK1
  - GNA15
  - GNAO1
  - RPS6
  - IFNAR1
  - GNAL
  - ATG16L1
  - ATG3
  - STAT2
  - GNAT3
  - RPTOR
  - MTOR
  - MAP1LC3A
  - IRS2
  - GNA14
  - MAPKAP1
  - RICTOR
  - GNAI3
  - MLST8
  - GNAS
  - GNAQ
  - Cancer
genes:
- word: IFN-a,
  symbol: IFN-ALPHA
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: GAS
  symbol: GAS
  source: hgnc_prev_symbol
  hgnc_symbol: GAST
  entrez: '2520'
- word: FOXOЗ
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAT1
  entrez: '2779'
- word: EIF4EBP1
  symbol: EIF4EBP1
  source: hgnc_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: FOXOЗ
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: IFN-
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: 4EBP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: IFN-E,
  symbol: IFNE
  source: hgnc_symbol
  hgnc_symbol: IFNE
  entrez: '338376'
- word: FOXOЗ
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: Atg12
  symbol: ATG12
  source: hgnc_symbol
  hgnc_symbol: ATG12
  entrez: '9140'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAZ
  entrez: '2781'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNA11
  entrez: '2767'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Atg10
  symbol: ATG10
  source: hgnc_symbol
  hgnc_symbol: ATG10
  entrez: '83734'
- word: EIF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
- word: EIF4B
  symbol: EIF4B
  source: hgnc_symbol
  hgnc_symbol: EIF4B
  entrez: '1975'
- word: FOXOЗ
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: IFN-B,
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: IFNAR2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: IFN-K
  symbol: IFNK
  source: hgnc_symbol
  hgnc_symbol: IFNK
  entrez: '56832'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: IRS1/IRS2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAT2
  entrez: '2780'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAI1
  entrez: '2770'
- word: Atg7
  symbol: ATG7
  source: hgnc_symbol
  hgnc_symbol: ATG7
  entrez: '10533'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNA15
  entrez: '2769'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAO1
  entrez: '2775'
- word: RPS6
  symbol: RPS6
  source: hgnc_symbol
  hgnc_symbol: RPS6
  entrez: '6194'
- word: IFNAR1
  symbol: IFNAR1
  source: hgnc_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: Atg16L1
  symbol: ATG16L1
  source: hgnc_symbol
  hgnc_symbol: ATG16L1
  entrez: '55054'
- word: Atg3
  symbol: ATG3
  source: hgnc_symbol
  hgnc_symbol: ATG3
  entrez: '64422'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: LC3
  symbol: LC3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP1LC3A
  entrez: '84557'
- word: IRS1/IRS2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNA14
  entrez: '9630'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAI3
  entrez: '2773'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: C/GA/TAAACIA
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3924851__F2
redirect_from: /figures/PMC3924851__F2
figtype: Figure
---
